Pharma: Other News To Note
Monday, September 23, 2013
• Otsuka Pharmaceutical Co. Ltd., of Tokyo, and H. Lundbeck A/S, of Copenhagen, Denmark, said the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorization for Abilify Maintena (aripiprazole), an intramuscular depot formulation for maintenance treatment of schizophrenia in adults stabilized with oral aripiprazole.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.